Drug repurposing: from large-scale biological data to therapeutics

July 08, 2022
One of the challenges we are facing today is the high cost and slow pace of drug development for many disease areas such as cancer, CNS, rare diseases etc. Repurposing drugs for new indications will have a shorter developmental time, lower cost, and less safety risk than the traditional drug development process.

Join us for this 60-minute Webinar on Drug repurposing: from large-scale biological data to therapeutics. This one-hour event will show how our platform enables biologists to leverage transcriptomics and literature-curated biological data for in-silico drug repositioning and repurposing.

Through a series of short demonstrations, we will explore:
• A systems biology approach to discover new uses of existing FDA-approved drugs
• Accelerate drug discovery process and generate novel hypotheses from high-quality omics and literature curated data
• Estimate network of genes potentially perturbed by drugs and integrate it with drug and disease gene expression signatures
• Study how targets of interest are expressed across different diseases and tissues

Our system uses millions of curated literature findings in the QIAGEN/ IPA knowledgebase and the OmicSoft digital warehouse. The presentation is intended for both those familiar with Ingenuity Pathway and newcomers interested in learning more.

Related videos


Somatic variants investigation in critical regulatory pathways

77 views August 25, 2022

This training will focus on using QIAGEN Ingenuity Pathway analysis (IPA) and...

Discovery and Research

Multi-omic changes in the postnatal mouse heart identified by QIAGEN Ingenuity Pathway Analysis...

341 views May 18, 2020

Multi-omics experiments allow researchers to make important discoveries in...

Discovery and Research

Using QIAGEN Digital Insights to determine how LY6E impairs coronavirus fusion and confers immune...

381 views May 08, 2020

Zoonotic coronaviruses (CoVs) are significant threats to global health, as...


Single Cell Analysis of the tumor microenvironmnet in High-grade Serous Ovarian Cancer (HGSOC)

66 views November 03, 2022

Single-cell RNA sequencing (scRNA-seq) is an important technology that...